SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-364451
Filing Date
2015-11-03
Accepted
2015-11-03 16:58:35
Documents
11
Period of Report
2015-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d29212d8k.htm 8-K 16204
2 EX-10.1 d29212dex101.htm EX-10.1 282162
3 EX-99.1 d29212dex991.htm EX-99.1 8871
4 GRAPHIC g29212ex10_1footer.jpg GRAPHIC 8570
5 GRAPHIC g29212ex10_1pg35.jpg GRAPHIC 166981
6 GRAPHIC g29212ex10_1pg36.jpg GRAPHIC 192950
7 GRAPHIC g29212ex10_1pg44.jpg GRAPHIC 183084
8 GRAPHIC g29212ex10_1pg45.jpg GRAPHIC 221425
9 GRAPHIC g29212ex10_1pg46.jpg GRAPHIC 181183
10 GRAPHIC g29212ex10_1pg47.jpg GRAPHIC 178487
11 GRAPHIC g29212ex10_1pg48.jpg GRAPHIC 174817
  Complete submission text file 0001193125-15-364451.txt   2110472
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37601 | Film No.: 151194401
SIC: 2836 Biological Products, (No Diagnostic Substances)